251 related articles for article (PubMed ID: 15009635)
1. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity.
Klivenyi P; Starkov AA; Calingasan NY; Gardian G; Browne SE; Yang L; Bubber P; Gibson GE; Patel MS; Beal MF
J Neurochem; 2004 Mar; 88(6):1352-60. PubMed ID: 15009635
[TBL] [Abstract][Full Text] [Related]
2. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.
Andreassen OA; Ferrante RJ; Dedeoglu A; Albers DW; Klivenyi P; Carlson EJ; Epstein CJ; Beal MF
Exp Neurol; 2001 Jan; 167(1):189-95. PubMed ID: 11161607
[TBL] [Abstract][Full Text] [Related]
3. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
Klivenyi P; Andreassen OA; Ferrante RJ; Dedeoglu A; Mueller G; Lancelot E; Bogdanov M; Andersen JK; Jiang D; Beal MF
J Neurosci; 2000 Jan; 20(1):1-7. PubMed ID: 10627575
[TBL] [Abstract][Full Text] [Related]
4. Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases.
Calingasan NY; Ho DJ; Wille EJ; Campagna MV; Ruan J; Dumont M; Yang L; Shi Q; Gibson GE; Beal MF
Neuroscience; 2008 Jun; 153(4):986-96. PubMed ID: 18423880
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model.
Naseri NN; Xu H; Bonica J; Vonsattel JP; Cortes EP; Park LC; Arjomand J; Gibson GE
J Neuropathol Exp Neurol; 2015 Jun; 74(6):527-37. PubMed ID: 25978848
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species.
Starkov AA; Fiskum G; Chinopoulos C; Lorenzo BJ; Browne SE; Patel MS; Beal MF
J Neurosci; 2004 Sep; 24(36):7779-88. PubMed ID: 15356189
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins.
Yang L; Shi Q; Ho DJ; Starkov AA; Wille EJ; Xu H; Chen HL; Zhang S; Stack CM; Calingasan NY; Gibson GE; Beal MF
Neurobiol Dis; 2009 Nov; 36(2):320-30. PubMed ID: 19660549
[TBL] [Abstract][Full Text] [Related]
8. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration.
Fernagut PO; Diguet E; Bioulac B; Tison F
Exp Neurol; 2004 Jan; 185(1):47-62. PubMed ID: 14697318
[TBL] [Abstract][Full Text] [Related]
9. MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Yamaguchi H; Kajitani K; Dan Y; Furuichi M; Ohno M; Sakumi K; Kang D; Nakabeppu Y
Cell Death Differ; 2006 Apr; 13(4):551-63. PubMed ID: 16273081
[TBL] [Abstract][Full Text] [Related]
10. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
Sun Z; Xie J; Reiner A
Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
[TBL] [Abstract][Full Text] [Related]
11. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
[TBL] [Abstract][Full Text] [Related]
12. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases.
Schulz JB; Matthews RT; Klockgether T; Dichgans J; Beal MF
Mol Cell Biochem; 1997 Sep; 174(1-2):193-7. PubMed ID: 9309687
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in L-12/15 lipoxygenase show increased vulnerability to 3-nitropropionic acid neurotoxicity.
He Y; Akumuo RC; Yang Y; Hewett SJ
Neurosci Lett; 2017 Mar; 643():65-69. PubMed ID: 28229935
[TBL] [Abstract][Full Text] [Related]
14. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice.
Bolin LM; Strycharska-Orczyk I; Murray R; Langston JW; Di Monte D
J Neurochem; 2002 Oct; 83(1):167-75. PubMed ID: 12358740
[TBL] [Abstract][Full Text] [Related]
15. 3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease.
Miller PJ; Zaborszky L
Exp Neurol; 1997 Jul; 146(1):212-29. PubMed ID: 9225755
[TBL] [Abstract][Full Text] [Related]
16. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
Yang L; Sugama S; Mischak RP; Kiaei M; Bizat N; Brouillet E; Joh TH; Beal MF
Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
18. Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Dedeoglu A; Albers DS; Kowall NW; Beal MF
Exp Neurol; 2001 Apr; 168(2):356-63. PubMed ID: 11259123
[TBL] [Abstract][Full Text] [Related]
19. Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid.
Dedeoglu A; Ferrante RJ; Andreassen OA; Dillmann WH; Beal MF
Exp Neurol; 2002 Jul; 176(1):262-5. PubMed ID: 12093104
[TBL] [Abstract][Full Text] [Related]
20. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
